DrugBank

JUNE 27, 2024

We are also seeing exciting partnerships between pharmaceutical companies and academics, as they have shown their ability to complement each other in discovering new repurposing opportunities.

Drugs 98

Drugs Pharma Companies Clinical Trials Computational Chemistry 98

DrugBank

OCTOBER 17, 2024

By harnessing the vast amounts of data generated throughout the development pipeline, pharmaceutical companies can accelerate the discovery of novel therapies, optimize clinical trial design, enhance drug safety monitoring, and deliver personalized medicine, ultimately improving patient outcomes and transforming the future of healthcare.

Drug Development 98

Drug Development Metabolic Stability Clinical Trials Drugs 98

Practical Cheminformatics

DECEMBER 7, 2023

A recent editorial by Dean Brown in J Med Chem and follow-up posts by Keith Hornberger and Derek Lowe prompted me to think about how we train computational chemists and cheminformaticians for careers in drug discovery. It also brought to mind some unique differences between how computational chemistry is practiced in biotech and pharma.

Computational Chemistry 86

Computational Chemistry Pharmacokinetics Drugs Pharmaceutical Companies 86

Sygnature Discovery

MAY 9, 2022

They have established multiple collaborations with renowned pharmaceutical companies and successfully developed the AI software platforms Makya™ for new drug design and Spaya™ for synthesis planning.

Computational Chemistry 52

Computational Chemistry Pharmaceutical Companies Science Drugs 52

Sygnature Discovery

JULY 31, 2023

Founded in 2011, NuChem Sciences delivers expert integrated and standalone discovery solutions across medicinal, synthetic, scale-up, process and computational chemistry, as well as DMPK, in vitro biology and in vivo pharmacology.

Computational Chemistry 52

Computational Chemistry Science Pharmaceutical Companies Clinical Trials 52

The Pharma Data

DECEMBER 13, 2020

Since its establishment, Viva Biotech has been providing comprehensive new drug R&D services to nearly 500 world’s top pharmaceutical and biotech companies based on Viva’s excellence in structure-based drug discovery. Dr. Xueheng Cheng, CTO of Viva Biotech, introduced the ASMS technology platform.

Small Molecule 40

Small Molecule Computational Chemistry Pharmaceuticals Production 40

The Pharma Data

NOVEMBER 15, 2020

” Arthur Oubrie, Chief Scientific Officer of Lead Pharma, added: “This is the second project we partner with one of the largest pharmaceutical companies under our Discover, Design and Deliver platform. . Lead Pharma may receive payments of up to €260 million plus royalties on sales. OSS, Netherlands , Nov.

Small Molecule 52

Small Molecule Licensing Licensing Disease 52